Yidu Tech's FY2025 revenue declines, loss narrows significantly

Yidu Tech Inc. (HKEX:2158), a prominent AI healthcare company, announced its annual results for the fiscal year ended March 31, 2025, revealing a mixed performance. Revenue decreased by 11.4% year-over-year, totaling RMB715.0 million compared to RMB807.1 million in FY2024. This decline was primarily attributed to reduced revenue in its Life Science Solutions and Health Management Platform and Solutions segments. However, the company significantly narrowed its losses for the year by 38.9%, reporting a loss of RMB135.2 million compared to RMB221.2 million in the previous fiscal year. This improvement was fueled by enhanced internal operational efficiency and increased synergies across its business segments. The Big Data Platform and Solutions segment saw a 10.3% revenue increase to RMB345.9 million. Yidu Tech's cash reserves remained strong, with cash and cash equivalents, term deposits, and other deposits totaling RMB3,309.1 million. The Board of Directors did not recommend a final dividend.